| Literature DB >> 34917489 |
Noppamad Tangmanee1, Sombat Muengtaweepongsa2, Wiroj Limtrakarn3.
Abstract
Many patients have significantly lower limb weakness after getting a stroke. Continuous regular physical therapy is essential to promote the improvement of the weakness and overall outcomes. Home rehabilitation provides motivation and enhances regular rehabilitation in stroke patients. The Do-It-Yourself (DIY) medical device is developed to fill the gap of unmet medical management needs and becomes increasingly applied in rehabilitation. The DIY device should support the concept of home rehabilitation in stroke patients. We designed and developed a low-cost, easy-to-use, DIY rehabilitation device to promote regular physical therapy in stroke patients with lower limb weakness. The methods and rationale of device development were described. The feasibility and safety of the device were also evaluated.•The DIY rehabilitation device for the lower limb is convenient and easy to assembly.•Regular home rehabilitation is enhanced with the DIY rehabilitation device.•The device is feasible and safe for physical therapy in stroke patients with lower limb weakness.Entities:
Keywords: Do-It-Yourself (DIY); Home rehabilitation; Leg weakness; Medical device; Stroke rehabilitation
Year: 2021 PMID: 34917489 PMCID: PMC8666558 DOI: 10.1016/j.mex.2021.101582
Source DB: PubMed Journal: MethodsX ISSN: 2215-0161
Fig. 1Design model by Solid Works; can be used for either left or right lower limb.
Fig. 2Free body diagram of patient's leg during knee flexion and extension exercise.
Fig. 3Free body diagram of exoskeleton during knee flexion and extension exercise.
Fig. 4Free body diagram of patient's leg during bridging exercise.
Fig. 5Free body diagram of patient's foot during ankle flexion and extension.
Fig. 6Control circuit of the lower limb rehabilitation machine.
Fig. 7A. hip flexion-extension, knee flexion-extension, ankle dorsiflexion-plantarflexion. B. hip bridging.
Demographic data (Mean±SD) of two groups
| Demographic characteristics | Experimental group (n = 10) | Control group (n = 10) | p-value |
|---|---|---|---|
| Age (years) | 53.8 ± 6.14 | 59.2 ± 2.28 | 0.58 |
| Gender | |||
| male | 6 | 7 | |
| female | 4 | 3 | |
| Paretic side | |||
| left | 8 | 9 | 0.15 |
| right | 2 | 1 | |
| Time from onset (days) | 3.9 ± 1.38 | 4.1 ± 1.28 | 0.43 |
| NIHSS | 11.58 ± 3.42 | 10.33 ± 2.92 | 0.68 |
| Brunnstrom stage | 2.50 ± 0.53 | 2.50 ± 0.53 | 0.60 |
NISS = National Institute of Health Stroke Scale
Outcome measure (Means±SD) compared the Fugl-Meyer Assessment for lower extremity (FMA-LE), Brunstrom Stage of Motor Recovery (Lower extremity), and modified Rankin scale before treament, weeks 2, 4, 8, and 12 of both groups.
| Outcome measure | Week | Experimental | Control | p-value |
|---|---|---|---|---|
| 14.50 ± 1.58 | 13.60 ± 1.26 | |||
| 17.40 ± 1.71 | 15.60 ± 1.30 | 0.04 | ||
| 21.50 ± 2.22 | 19.60 ± 1.90 | 0.043 | ||
| 26.80 ± 1.87 | 23.01 ± 1.76 | 0.03 | ||
| 30.10 ± 1.79 | 27.40 ± 1.89 | 0.03 | ||
| 2.50 ± 0.53 | 2.50 ± 0.53 | |||
| 3.10 ± 0.47 | 2.80 ± 0.56 | 0.52 | ||
| 3.70 ± 0.85 | 3.20 ± 0.57 | 0.73 | ||
| 4.90 ± 0.57 | 4.00 ± 0.74 | 1.00 | ||
| 5.60 ± 0.52 | 4.60 ± 0.72 | 0.037 | ||
| 4.00 ± 0.52 | 4.10 ± 0.12 | |||
| 3.60 ± 0.50 | 3.80 ± 0.72 | 1.00 | ||
| 3.40 ± 0.42 | 3.20 ± 0.47 | 0.97 | ||
| 2.60 ± 0.67 | 2.80 ± 0.79 | 1.00 | ||
| 2.20 ± 0.70 | 2.60 ± 0.31 | 1.02 |
Significant difference in gains, p < 0.05
Outcome measure (Means±SD) compared the Fugl-Meyer Assessment for lower extremity (FMA-LE), Brunstrom Stage of Motor Recovery (Lower extremity), and modified Rankin scale before treatment and after treatment of two group.
| Outcome measure | Group | Before treatment | After treatment (Week 12) | p-value |
|---|---|---|---|---|
| FMA-LE | Experimental | 14.50 ± 1.58 | 30.10 ± 1.79 | 0.03 |
| Control | 13.60 ± 1.26 | 27.40 ± 1.89 | 0.01 | |
| Brunstrom Stage | Experimental | 2.50 ± 0.53 | 5.60 ± 0.52 | 0.01 |
| Control | 2.50 ± 0.53 | 4.60 ± 0.72 | 0.02 | |
| Modified Rankin Scale | Experimental | 4.00 ± 0.52 | 2.20 ± 0.70 | 0.02 |
| Control | 4.10 ± 0.12 | 2.60 ± 0.31 | 0.00 |
Significant difference in gains, p<0.05
| Subject area: | Medicine and dentistry |
| More specific subject area: | |
| Method name: | |
| Name and reference of original method: | |
| Resource availability: |